Wall Street’s Top Analysts Upgrades, Downgrades & Initiations

Wall Street’s Top Analysts Upgrades, Downgrades & Initiations

$BLUS, $CRI, $CTSH, $CFX, $ECL

Daily HeffX-LTN reviews Wall Street analysts research reports to find new investing and trading ideas for our readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.

Below is a list of Wall Street’s Top analysts outlook for Key issues for Friday, as follows:

Bluebird Bio Inc. (NASDAQ:BLUE) has seen mixed results after earnings. BMO Capital Markets maintained its Outperform rating and raised its target price to 222 from 215. Cantor Fitz reiterated its Underweight rating.

Carter’s Inc. (NYSE:CRI) was reiterated as Outperform and the price target was raised to 135 from 125 at Oppenheimer.

Cognizant Technology Solutions Corp. (NASDAQ:CTSH) was raised to Buy from Hold with a 100 price target at Argus.

Colfax Corp. (NYSE:CFX) was reiterated as Buy with a 40 price target at Argus, with the independent research shop saying that the recent weakness offers a buying opportunity.

Ecolab Inc. (NYSE:ECL) was reiterated as Buy with a 150 price target at Argus, which noted that solid earnings and a raised dividend should help rectify its under-performance as a stock over the past quarter.

Have a terrific weekend.

The following two tabs change content below.

Paul Ebeling

Paul A. Ebeling, polymath, excels in diverse fields of knowledge. Pattern Recognition Analyst in Equities, Commodities and Foreign Exchange and author of “The Red Roadmaster’s Technical Report” on the US Major Market Indices™, a highly regarded, weekly financial market letter, he is also a philosopher, issuing insights on a wide range of subjects to a following of over 250,000 cohorts. An international audience of opinion makers, business leaders, and global organizations recognizes Ebeling as an expert.

You must be logged in to post comments :  
CONNECT WITH